Sunitinib adverse event: Oral bullous and lichenoid mucositis

Annals of Pharmacotherapy

Volumn 43, Issue 3, 2009, Pages 546-547

  Mignogna, Michele Davide ^a   Fortuna, Giulio ^a   Leuci, Stefania L ^a   Sciences, Maxillofacial ^a   Pollio, Annamaria ^a   Ruoppo, Elvira ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; SUNITINIB; ZOLEDRONIC ACID;

ADULT; ANAMNESIS; AUTOIMMUNE DISEASE; BLISTER; BREAST CANCER; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LICHENOID; LYMPHOCYTOPENIA; METASTASIS; MOUTH EXAMINATION; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; VESICULAR RASH;

ANTINEOPLASTIC AGENTS; BLISTER; FEMALE; HUMANS; INDOLES; LICHENOID ERUPTIONS; MIDDLE AGED; PYRROLES; STOMATITIS;

EID: 62949244152     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L592     Document Type: Letter

References (8)

1. Burstein HJ, Elias AD, Rugo HS, et al. Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol 2008;26:1810-6.
2. Adams VR, Leggas M. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors. Clin Ther 2007; 29:1338-53.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Kollmannsberger C, Soulieres D, Wong R, Scalera A, Gaspo R, Bjarnason G. Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects. Can Urol Assoc J 2007; 1 :S41-54.
5. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 1994;42:1417-25.
6. Morita E, Lee DG, Sugiyama M, Yamamoto S. Expression of c-kit ligand in human keratinocytes. Arch Dermatol Res 1994;286:273-7.
7. Wilgus TA, Matthies AM, Radek KA, et al. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 2005;167:1257-66.
8. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006; 168:639-48.